Work

P2.10.13 Sunvozertinib Combined With Bevacizumab in Previously Treated Advanced NSCLC With EGFR Exon 20 Insertion Mutations

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.707

Authors: Y. Yu, Y. Zhang, L. Chu, X. Yu, D. Lv, Q. Song, Q. Wang, W. Guo, X. Chen, J. Hu, S. Cang, M. Zhao, H. Su, Y. Wang, X. Pan, M. Wang, S. Lu

Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital, Hunan Cancer Hospital, Fudan University Shanghai Cancer Center, Zhejiang Cancer Hospital, Renmin Hospital of Wuhan University, Henan Cancer Hospital, Union Hospital, Fudan University, Zhongshan Hospital, Henan Provincial People's Hospital, First Hospital of China Medical University, Tang Du Hospital, Dizal (Jiangsu) Pharmaceutical Co., Ltd. (China)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519569

FWCI: 0.53

Cites:

Cited by: 1

Related to: 10